CClinicalTrials.gg
CompletedNCT04247789Updated Feb 21, 2020

The Associated Factors With Fatigue in Older Adults Living in a Rest Home

An observational study in Fatigue and Older People--Abuse of, sponsored by T.C. ORDU ÜNİVERSİTESİ. Completed at 1 site in Turkey. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2020-02-21.

Sponsored by T.C. ORDU ÜNİVERSİTESİ · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Cross-sectional
Enrollment
92
Ages
65 Years and older
Sex
All
01

Study summary

Fatigue is an important and prevalent problem in older adults. The ratio of fatigue may rise in older adults who live in nursing homes/rest homes. In the literature, a few studies investigated the prevalence of fatigue, and there is no study explaining the associated factors. The aim of the present study is to investigate the prevalence of fatigue in rest home residents and to determine the associated variables with fatigue.

02

Conditions studied

  • Fatigue
  • Older People--Abuse of

Browse trials for

Keywords

  • fatigue
  • physical function
  • strength
  • older adults
  • nursing homes
03

In context

Fatigue

1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.

This study's enrollment of 92 is close to the median of 100 across 367 observational studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

T.C. ORDU ÜNİVERSİTESİ is the lead sponsor of 87 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The older adults living in a rest home

Inclusion criteria

  • age older than 65 years
  • able to walk with/without walking device
  • living at a rest home for at least 12 months
  • being voluntary for all assessments

Exclusion criteria

Exclusion Criteria:

  • had a cognitive problem (MMSE\<24 scores)
  • had a neurologic disorder
  • had a cancer history
  • had uncontrolled cardiopulmonary dysfunction
05

Study design

Observational model
Case-crossover
Time perspective
Cross-sectional
Enrollment
92 participants (actual)
Patient registry
No

Groups and cohorts

  • Total sample

    This group consists of older adults living in a rest home, who are proper for inclusion criteria

    Other: Self-reported questionairres

Interventions

  • OtherSelf-reported questionairres

    the fatigue will be determined through self reported questionnairres

06

What researchers measure

Primary outcomes

  1. Fall Severity Scale (FSS)

    The FSS is the most frequently used scale among the unidimensional scales which have been developed to assess fatigue. The scale rates the fatigue with nine items, For each item, the patient is asked to grade the fatigue level between 1 and 7, where 1 indicates strong disagreement and 7 indicates strong agreement. A score of 28 or higher generally indicates presence of fatigue.

    Time frame: 5 minutes

Secondary outcomes

  1. Strength assessment

    Quadriceps strength and handgrip strength will be measured by digital dynamometers named as Lafayette and Jamar dynamometers, respectively. Quadriceps strength will be measured in a sitting position with hip and knee flexed 90 degrees. The participants extend the knee and the examiner applies an opposite force to break this position. This test will be performed three times and the maximum value will be recorded in a kilogram. The handgrip strength will be assessed according to the American Society of Hand Therapists. The participants will be asked to squeeze as forcefull as possible the dynamometer. The maximum score of three trials will be recorded in kliograms.

    Time frame: 5 minutes

  2. Functional Capacity

    Six-minutes walk test will be used to evaluate the functional capacity or cardiorespiratory fitness. The participants will be walking in a 30-meter corridor for 6-minutes. If necessary the participants can use the walking assistive devices and take a rest. The total distance will be recorded in meters.

    Time frame: 6-10 minutes

  3. Physical Function

    Short Physical Performance Battery will be used to measure physical functioning. This battery includes 3 subdomains (gait speed, balance and chair stand test). The totatl score changes between 0 and 12. The higher score indicates better performance.

    Time frame: 5 minutes

  4. Boddy mass index

    The body measures (weight and height) will be assessed in kilograms and meters. The index will be calculated by dividing body weight by height squared.

    Time frame: 2 minutes

  5. Physical activity habits

    Physical activity habits will be determined with a question" How many times did you exercise for 30 minutes or more with a certain tempo?" This question will be recorded as a dichotomous variable, 1 indicates present physical activity habits (\>2 times) and 0 no physical activity habits (\<3 times).

    Time frame: 1 minutes

  6. Body mass

    The weight will be measured in kilograms without shoes and within thin clothes

    Time frame: 30 seconds.

  7. Body Height

    The height will be determined in an erect standing position as centimeters.

    Time frame: 30 seconds

07

Study locations

1 site
  • Sevim ACARÖZ CANDAN
    Ordu, Altinordu 52100, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04247789
Lead sponsor
T.C. ORDU ÜNİVERSİTESİ
Responsible party
Sevim ACARÖZ CANDAN (Phsiotherapy and Rehabilitation Department, T.C. ORDU ÜNİVERSİTESİ) — Principal investigator
First posted
Jan 30, 2020
Start date
Dec 23, 2019
Primary completion
Jan 31, 2020
Completion
Feb 5, 2020
Last update
Feb 21, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion